Literature DB >> 4604991

Pure red-cell aplasia.

S B Krantz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604991     DOI: 10.1056/NEJM197408152910707

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Adult pure red cell aplasia following topical ocular chloramphenicol.

Authors:  T Fernandez de Sevilla; J Alegre; T Vallespi; V Falco; J M Martinez-Vazquez
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

2.  Red cell aplasia in children.

Authors:  B P Alter; D G Nathan
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

3.  Pure red cell hypoplasia associated with long-arm deletion of chromosome 5.

Authors:  J DiBenedetto; T Padre-Mendoza; M M Albala
Journal:  Hum Genet       Date:  1979-02-15       Impact factor: 4.132

4.  A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.

Authors:  Haruko Ideguchi; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

5.  Pure red cell hypoplasia secondary to isoniazid.

Authors:  C R Lewis; A Manoharan
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

Review 6.  Red cell aplasia following prolonged D-penicillamine therapy.

Authors:  J L Gollan; S Hussein; A V Hoffbrand; S Sherlock
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

7.  T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

Authors:  K F Mangan; G Chikkappa; P C Farley
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution.

Authors:  Angel Alonso Melgar; Marta Melgosa Hijosa; Rafael Pardo de la Vega; Carmen García Meseguer; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2004-05-07       Impact factor: 3.714

9.  Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

Authors:  Parnell Mattison; Kiran Upadhyay; Jennifer E Wilcox; Asha Moudgil; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

10.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.